Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
13,745,019
-
Share change
-
-155,912
-
Total reported value
-
$114,358,000
-
Price per share
-
$8.32
-
Number of holders
-
28
-
Value change
-
-$1,038,096
-
Number of buys
-
15
-
Number of sells
-
9
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2015
As of 31 Mar 2015 GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) had 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,745,019 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, Candriam Luxembourg S.C.A., VANGUARD GROUP INC, WALL STREET ASSOCIATES, Spark Investment Management LLC, JPMORGAN CHASE & CO, and GOLDMAN SACHS GROUP INC.
This table shows 28 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.